Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The calcium channel protein alpha1 subunit is the principal pore-forming component of voltage-gated calcium channels (VGCCs). It mediates calcium influx in response to membrane depolarization and determines the channel's biophysical and pharmacological properties. Multiple isoforms exist (CaV1.x, CaV2.x, CaV3.x), each with distinct tissue distributions and functions. Accessory subunits modulate the alpha1 subunit's activity. Mutations in genes encoding alpha1 subunits are associated with various diseases.
Calcium channel blockade, reducing calcium influx into cells
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Calcium Channel Protein Alpha1 Subunit (CACNA1).